May 11, 2023
Most adults in the United States (70%) are anxious or extremely anxious about keeping themselves or their families safe, with 42% very anxious about gun violence, […]
May 11, 2023
While they’re much less likely to develop chronic lymphocytic leukemia (CLL) than are White patients, African-American patients with this blood cancer are detected later and die […]
May 11, 2023
LOS ANGELES — A new report shows that spin, including signs of exaggeration and mathematical errors, was seen in 21% of 150 randomized traumatic brain injury […]
May 11, 2023
PHOENIX – Ever since PicoSure became the first picosecond laser cleared by the Food and Drug Administration for the treatment of unwanted tattoos and pigmented lesions in […]
May 11, 2023
The US Food and Drug Administration (FDA) has approved pegunigalsidase alfa (Elfabrio, Chiesi Global Rare Diseases/Protalix BioTherapeutics), an enzyme replacement therapy (ERT) to treat adults with […]
May 11, 2023
NEW YORK (Reuters) – Vyera Pharmaceuticals, which previously settled price-fixing charges that resulted in founder Martin Shkreli being banned from the pharmaceutical industry, filed for bankruptcy […]
May 11, 2023
In two phase 3 trials, patients with prurigo nodularis (PN) randomized to receive dupilumab every 2 weeks for 24 weeks achieved statistically significant improvements in itch […]
May 11, 2023
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. When the federal government’s Public Health Emergency (PHE) ended on May 11, […]